Nirmal Kaur MDDirector, Inflammatory Bowel Disease Center, Henry Ford Health System, Novi, Michigan
Dr. Kaur is the Director of the Inflammatory Bowel Disease Center at Henry Ford Health System in Detroit, Michigan. She serves as Principal Investigator on several clinical trials related to IBD, and has implemented a system for adherence to AGA quality measures for all IBD patients at Henry Ford. Dr. Kaur completed her residency and fellowship training at the University of Michigan in 2010.
Present: Consultant, Takeda Pharmaceuticals; Research funding, Janssen Pharmaceuticals, Genentech-Roche Pharmaceuticals, AbbVie PharmaceuticalsPast: Consultant, AbbVie Pharmaceuticals; AMAG Pharmaceuticals; UCB Pharmaceuticals